Finance

Lists
HLNCF:OTCMKTS
Haleon PLC
4,95 US$
+1,21%
(+0,059) 1D
16 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HLNCF...
Open
4,81 US$
High
4,98 US$
Low
4,81 US$
Mkt. cap
44,32 მლრდ.
Avg. vol.
10,03 ათ.
Volume
17,69 ათ.
52-wk high
5,75 US$
52-wk low
4,15 US$
Beta
-21,47
Shares outstanding
8,80 მლრდ.
No. of employees
25 ათ.
Open
4,81 US$
High
4,98 US$
Low
4,81 US$
Mkt. cap
44,32 მლრდ.
Avg. vol.
10,03 ათ.
Volume
17,69 ათ.
52-wk high
5,75 US$
52-wk low
4,15 US$
Beta
-21,47
Shares outstanding
8,80 მლრდ.
No. of employees
25 ათ.
News stories
From web sources and news partners
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022. Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC
CEO-
Employees24,5 ათ.
Founded18 ივლ. 2022
Headquarters-
SectorPharmaceutical industry
Websitehaleon.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,78 მლრდ.
2,78 მლრდ.
2,80 მლრდ.
2,80 მლრდ.
Cost of goods sold
970,50 მლნ.
970,50 მლნ.
949,50 მლნ.
949,50 მლნ.
Cost of revenue
970,50 მლნ.
970,50 მლნ.
949,50 მლნ.
949,50 მლნ.
Research and development expenses
81,50 მლნ.
81,50 მლნ.
73,50 მლნ.
73,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,08 მლრდ.
1,08 მლრდ.
1,11 მლრდ.
1,11 მლრდ.
Operating expense
1,16 მლრდ.
1,16 მლრდ.
1,18 მლრდ.
1,18 მლრდ.
Total operating expenses
2,13 მლრდ.
2,13 მლრდ.
2,13 მლრდ.
2,13 მლრდ.
Operating income
643,00 მლნ.
643,00 მლნ.
670,50 მლნ.
670,50 მლნ.
Other non operating income
-10,50 მლნ.
-10,50 მლნ.
1,50 მლნ.
1,50 მლნ.
EBT including unusual items
538,50 მლნ.
538,50 მლნ.
528,00 მლნ.
528,00 მლნ.
EBT excluding unusual items
552,00 მლნ.
552,00 მლნ.
612,50 მლნ.
612,50 მლნ.
Income tax expense
105,00 მლნ.
105,00 მლნ.
143,00 მლნ.
143,00 მლნ.
Effective tax rate
19,50%
19,50%
27,08%
27,08%
Other operating expenses
-
-
-
-
Net income
430,50 მლნ.
430,50 მლნ.
381,00 მლნ.
381,00 მლნ.
Net profit margin
15,51%
15,51%
13,60%
13,60%
Earnings per share
-
-
-
-
Interest and investment income
5,00 მლნ.
5,00 მლნ.
17,00 მლნ.
17,00 მლნ.
Interest expense
-85,50 მლნ.
-85,50 მლნ.
-76,50 მლნ.
-76,50 მლნ.
Net interest expenses
-80,50 მლნ.
-80,50 მლნ.
-59,50 მლნ.
-59,50 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
704,50 მლნ.
704,50 მლნ.
724,00 მლნ.
724,00 მლნ.
Gain or loss from assets sale
-
-
-10,00 მლნ.
-10,00 მლნ.
AI content may include mistakes. Learn more
Google აპები